Your browser doesn't support javascript.
loading
Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study).
Distler, Meike; Maul, Julia-Tatjana; Steiner, Urs C; Jandus, Peter; Kolios, Antonios G A; Murer, Carla; Graf, Nicole; Seebach, Jörg D; Pichler, Werner J; Navarini, Alexander A; French, Lars E; Helbling, Arthur; Schmid-Grendelmeier, Peter.
Affiliation
  • Distler M; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland, meike.distler@usz.ch.
  • Maul JT; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Steiner UC; Department of Immunology, University Hospital Zurich, Zurich, Switzerland.
  • Jandus P; Department of Rheumatology, Immunology and Allergology, University Hospital Berne, Berne, Switzerland.
  • Kolios AGA; Division of Immunology and Allergology, Department of Medical Specialties, Geneva University Hospital, Geneva, Switzerland.
  • Murer C; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Graf N; Department of Immunology, University Hospital Zurich, Zurich, Switzerland.
  • Seebach JD; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Pichler WJ; Graf Biostatistics, Zurich, Switzerland.
  • Navarini AA; Division of Immunology and Allergology, Department of Medical Specialties, Geneva University Hospital, Geneva, Switzerland.
  • French LE; Department of Rheumatology, Immunology and Allergology, University Hospital Berne, Berne, Switzerland.
  • Helbling A; ADR-AC GmbH Berne, Zurich, Switzerland.
  • Schmid-Grendelmeier P; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Dermatology ; 236(6): 529-539, 2020.
Article in En | MEDLINE | ID: mdl-31958790

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Mastocytosis, Systemic / Omalizumab Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Dermatology Journal subject: DERMATOLOGIA Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Allergic Agents / Mastocytosis, Systemic / Omalizumab Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Dermatology Journal subject: DERMATOLOGIA Year: 2020 Document type: Article